New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
04:55 EDTXLRN, XLRN, XLRN, AGIO, AGIO, AGIO, ALKS, ALKS, ALKS, ALNY, ALNY, ALNY, ARIA, ARIA, ARIA, EPZM, EPZM, EPZM, IMGN, IMGN, IMGN, TSRO, TSRO, TSROLeerink to hold a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 14-16.
News For XLRN;AGIO;ALKS;ALNY;ARIA;EPZM;IMGN;TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 21, 2015
05:37 EDTALKSAlkermes initiated with an Overweight at Barclays
Subscribe for More Information
May 20, 2015
10:29 EDTARIAOptions with decreasing implied volatility
Options with decreasing implied volatility: ZIOP KING ARIA CTRP WTW VHC XON KERX VIPS JCP
07:21 EDTXLRNUBS to hold a conference
Subscribe for More Information
07:04 EDTALNYAlnylam receives orphan drug designation for revusiran
Subscribe for More Information
May 19, 2015
11:59 EDTARIAOptions with decreasing implied volatilit
Subscribe for More Information
11:03 EDTALNYAlnylam transthyretin amyloidosis treatment designated for FDA orphan status
Alnylam's revusiran was designated by the FDA for orphan drug status as a treatment of transthyretin amyloidosis. Reference Link
08:57 EDTAGIOLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:28 EDTALNYUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 19 at 8 am; not all company presentations may be webcasted. Webcast Link
May 18, 2015
10:37 EDTARIAOptions with decreasing implied volatility
Options with decreasing implied volatility: NLNK ARWR CTRP ZIOP CLNE ARIA VHC AOL KING XON PEIX
07:37 EDTAGIOAgios Pharmaceuticals AG-120 granted FDA Fast Track designation
Subscribe for More Information
07:31 EDTXLRNCelgene, Acceleron granted fast track designations for luspatercept
Subscribe for More Information
May 17, 2015
15:24 EDTALNYAlnylam files ALN-AAT trial application, reports positive results in primates
Subscribe for More Information
May 15, 2015
08:51 EDTXLRNAcceleron management to meet with Leerink
Subscribe for More Information
May 14, 2015
08:04 EDTARIAARIAD to present data on Iclusig, brigatinib at ASCO meeting
Subscribe for More Information
07:40 EDTIMGNImmunoGen data 'impressive,' says Oppenheimer
Subscribe for More Information
May 13, 2015
17:59 EDTTSROTESARO to present seven abstracts at ASCO
Subscribe for More Information
17:41 EDTIMGNImmunoGen to present mirvetuximab data at 2015 ASCO meeting
Subscribe for More Information
17:40 EDTXLRNAcceleron to present DART study data at ASCO
Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, announced that data from the DART study, an ongoing phase 2 clinical trial of dalantercept in patients with advanced renal cell carcinoma will be presented at the 2015 American Society of Clinical Oncology, ASCO, Annual Meeting in Chicago, Illinois.
May 12, 2015
07:52 EDTALKS, TSRO, ALNY, EPZM, ARIA, AGIOLeerink to hold a tour
Subscribe for More Information
May 11, 2015
06:19 EDTALKSAlkermes management to meet with Jefferies
Meeting to be held in Baltimore on May 11 hosted by Jefferies.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use